ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2026
Prevalence of thyroid autoantibodies in a large series of sarcoidosis patients: Implications for autoimmune thyroid disease screening.
Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimSarcoidosis is a potentially multisystem granulomatous disease frequently associated with autoimmunity. Previous cohort studies have reported an elevated risk of developing autoimmune thyroid disease (AITD) in sarcoidosis patients. Aim of the study was to assess the prevalence of thyroid autoimmunity in a large, biopsy-proven sarcoidosis cohort and compare it to established general population rates, thereby highlighting the clinical significance of screening.
methodsTo explore the prevalence of AITD, we examined a cross-sectional cohort of 668 patients with biopsy-proven sarcoidosis. Serum Thyroperoxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb) were quantified using standard electrochemiluminescence immunoassays (ECLIA). The prevalence of positive thyroid autoantibodies was compared to previously published regional healthy control rates (11.4%, n=1,108) using a two-sample Z-test for comparing two proportions.
resultsThe overall prevalence of positive thyroid autoantibodies (TPOAb and/or TgAb) in the sarcoidosis cohort (n=668) was found to be 27.4% (95% CI: 21.7%-28.3%). This rate was significantly higher compared to the pooled historical control group prevalence of 11.4% (p < 0.001.
conclusionThe prevalence of positive thyroid autoantibodies in patients with sarcoidosis is significantly elevated compared to the healthy population. This finding underscores the strong autoimmune linkage between sarcoidosis and AITD and supports the recommendation for systematic screening for thyroid autoimmunity in patients diagnosed with sarcoidosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.